SUNNY OPTICAL(2382.HK)2025 OUTLOOK:DECENT SHARE GAIN WHILE AWAITING XR PRODUCT CYCLE
SUNNY OPTICAL(2382.HK)2025 OUTLOOK:DECENT SHARE GAIN WHILE AWAITING XR PRODUCT CYCLE
Looking into 2025, we believe Sunny Optical will benefit from a revived smartphone camera upgrade cycle led by domestic OEMs, US client share gain and the intensifying domestic NOA competition. Regarding XR, we believe it will likely serve as a key re-rate driver from mid-2025 when investors see more AR glasses rushing into market. We lift 2024- 26 EPS by 4-6% and lift TP from HK$69 to HK$77. Maintain BUY.
展望2025年,我們相信舜宇光學科技將受益於國內OEM主導的智能手機攝像頭升級週期的復甦、美國客戶市場份額的增長以及國內NOA競爭的加劇。關於XR,我們認爲從2025年中期開始,隨着投資者看到更多AR眼鏡湧入市場,它可能會成爲關鍵的再評級驅動因素。我們將2024-2026年的每股收益提高了4-6%,並將目標價從69港元上調至77港元。維持買入評級。
Key Factors for Rating
評級關鍵因素
2025 catalysts to watch out: during our recent roadshows, investors generally care about domestic fiscal stimulus on consumer electronics, camera upgrade, US client share gain, BYD (1211 HK/TP: HK$325.00, BUY) accelerating autonomous driving via upgrading automotive cameras, XR esp. AR AI glasses development, in regard to Sunny Optical. We feel a general positive sentiment as Company is on the recovery path, while some expressed concerns on 1) automotive lens margins outlook as domestic auto OEMs outgrowing overseas peers; 2) AR glass growth contribution may be small over 2025-26; and 3) the speculated smartphone national subsidy in 2025 may not come through as expected.
2025年值得關注的催化劑:在我們最近的路演中,投資者普遍關注消費電子的國內財政刺激、攝像頭升級、美國客戶市場份額增長、比亞迪(1211 HK/目標價:325.00港元,買入)通過升級汽車攝像頭加速自動駕駛、XR尤其是AR人工智能眼鏡的發展,針對舜宇光學科技。我們感到總體的積極情緒,因爲公司正在復甦的過程中,而一些人對以下問題表示擔憂:1)由於國內汽車OEM超過境外同行,汽車鏡頭的利潤前景;2)2025-2026年AR眼鏡增長貢獻可能較小;3)預計2025年的智能手機國家補貼可能不會按預期進行。
Smartphone: YTD shipment of HLS/HCM were +14.6% YoY / -7.7% YoY, vs 2024 guidance of +5-10% YoY / flat YoY. While overall smartphone demand remained in-line, strong HLS was due to share gain in key US client as well as robust Android high-end demand; on the contrary, HCM shipment was much weaker especially in 2H24 and Company attributed it to a strategic shift of focus to higher-end products. For instance, Sep/Oct/Nov HCM shipments were down -29.6%/-37.5%/-28.1% YoY while ASP of HCM were up more than 30-40% YoY as a result of mix shift. This also aligns with our recent channel check that peer companies collectively reported better HCM YoY growth in 2H24.
智能手機:截至目前HLS/HCm的出貨量同比增長14.6% / 下滑7.7%,而2024年的指導目標爲同比增長5-10% / 持平。儘管整體智能手機需求與預期持平,但HLS的強勁增長是由於在關鍵美國客戶的市場份額增長以及強勁的Android高端需求;相反,HCm的出貨量在2024年下半年尤其疲軟,公司將此歸因於戰略焦點轉向高端產品。例如,9月/10月/11月HCm的出貨量同比下降了-29.6%/-37.5%/-28.1%,而HCm的平均售價由於產品組合轉變上漲了30-40%以上。這也與我們最近渠道調查的結果一致,即同行公司在2024年下半年整體報告的HCm同比增長更好。
Automotive: we believe automotive will be a key growing segment in 2025 as more domestic auto OEMs enter autonomous driving or NOA race in late 2H24, which calls for acceleration of camera/LiDAR hardware adoption per car. We now forecast 2025 VLS shipment to grow +20% YoY (previously +12% YoY) and VCM revenue to grow 30% YoY (previously +20% YoY), mainly driven by more intense NOA competition such as BYD.
汽車:我們認爲汽車將成爲2025年關鍵的增長細分市場,因爲更多的國內汽車OEM將在2024年下半年進入自動駕駛或NOA競賽,這就需要每輛車加速採用攝像頭/激光雷達硬件。我們現在預測2025年VLS的出貨量將同比增長20%(之前爲12%),VCm的營業收入將同比增長30%(之前爲20%),主要受到比亞迪等NOA競爭加劇的推動。
XR: we believe from 2026, variances of edge AI devices will converge into AR AI glasses, from which the Company is able to hike on a new product cycle wave for its exposure in camera and waveguide optics. A new re-rate cycle of the Company will likely kick off from mid-2025 when more similar AR AI glasses being showcased.
XR:我們認爲從2026年開始,邊緣人工智能設備的差異將匯聚成增強現實人工智能眼鏡,因此公司能夠在其相機和波導光學領域迎來新的產品週期浪潮。公司新的重新評級週期可能在2025年中期開始,當時會展示更多類似的增強現實人工智能眼鏡。
Key Risks for Rating
評級風險關鍵因素
1) Demand miss for high spec smartphone; 2) slower-than-expected market share gain; 3) new price war initiated by peers; and 4) weak macro.
1)高規格智能手機需求不振;2)市場份額增長慢於預期;3)同行發起的新一輪價格戰;4)宏觀經濟疲軟。
譯文內容由第三人軟體翻譯。